161 related articles for article (PubMed ID: 2388855)
1. A less severe form of Haemophilia B Leyden.
Crossley M; Winship PR; Austen DE; Rizza CR; Brownlee GG
Nucleic Acids Res; 1990 Aug; 18(15):4633. PubMed ID: 2388855
[No Abstract] [Full Text] [Related]
2. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
[TBL] [Abstract][Full Text] [Related]
3. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
[No Abstract] [Full Text] [Related]
5. Factor IXBasel: a Swiss family with severe haemophilia B having a point mutation in EGF type B domain.
Alkan M; Rodriguez Ponte M; Malik NJ; Hofmann S; Bösch-Al Jadooa N; Müller H; Bühler EM
Nucleic Acids Res; 1991 Jan; 19(2):409. PubMed ID: 2014182
[No Abstract] [Full Text] [Related]
6. The putative factor IX gene promoter in hemophilia B Leyden.
Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
[TBL] [Abstract][Full Text] [Related]
8. A new case of severe hemophilia B Leyden, associated with a G to C mutation at position -6 of the factor IX promoter.
Nguyen P; Cornillet P; Potron G
Am J Hematol; 1995 Jul; 49(3):259-60. PubMed ID: 7604825
[No Abstract] [Full Text] [Related]
9. A single base pair deletion in the promoter region of the factor IX gene is associated with haemophilia B.
Hall AJ; Chuansumrit A; Peake IR; Winship PR
Thromb Haemost; 1994 Dec; 72(6):799-803. PubMed ID: 7740444
[TBL] [Abstract][Full Text] [Related]
10. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
[TBL] [Abstract][Full Text] [Related]
11. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B.
Crossley M; Brownlee GG
Nature; 1990 May; 345(6274):444-6. PubMed ID: 2342576
[TBL] [Abstract][Full Text] [Related]
12. Early elevation of factor IX level in japanese brothers with Haemophilia B Leyden who are carrying c. -35 g > a mutations in the promoter region of F9.
Tamura A; Shinozawa K; Uemura S; Nakamura S; Fujiwara T; Tahara T; Yamamoto N; Saito A; Kozaki A; Kishimoto K; Ishida T; Hasegawa D; Muramatsu T; Amano K; Fukutake K; Kosaka Y
Haemophilia; 2021 Jul; 27(4):e510-e512. PubMed ID: 33427373
[No Abstract] [Full Text] [Related]
13. Haemophilia B Leyden: the effect of mutations at position +13 on the liver-specific transcription of the factor IX gene.
Reijnen MJ; Maasdam D; Bertina RM; Reitsma PH
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):341-8. PubMed ID: 8075306
[TBL] [Abstract][Full Text] [Related]
14. Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
Picketts DJ; Lillicrap DP; Mueller CR
Nat Genet; 1993 Feb; 3(2):175-9. PubMed ID: 8499951
[TBL] [Abstract][Full Text] [Related]
15. Splice junction mutations in factor IX gene resulting in severe hemophilia B.
Chen SH; Zhang M; Thompson AR; Bray GL; Scott CR
Nucleic Acids Res; 1991 Mar; 19(5):1172. PubMed ID: 2020563
[No Abstract] [Full Text] [Related]
16. Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice.
Boland EJ; Liu YC; Walter CA; Herbert DC; Weaker FJ; Odom MW; Jagadeeswaran P
Blood; 1995 Sep; 86(6):2198-205. PubMed ID: 7662969
[TBL] [Abstract][Full Text] [Related]
17. A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter + 13 A>G).
James PD; Stakiw J; Leggo J; Walker I; Lillicrap D
J Thromb Haemost; 2008 May; 6(5):885-6. PubMed ID: 18315547
[No Abstract] [Full Text] [Related]
18. Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B.
Thompson AR; Schoof JM; Weinmann AF; Chen SH
Thromb Res; 1992 Jan; 65(2):289-95. PubMed ID: 1579901
[No Abstract] [Full Text] [Related]
19. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
